The connection between the AR pathway and DNA repair in PCA proved to be so tight that, even in the absence of pathogenic mutations in DNA repair genes, there is a possibility of targeted therapeutic interventions using PARPi. The gene discussed is AR; the disease is posterior cortical atrophy.